Changes in the Composition of the Human Fecal Microbiome After Bacteriotherapy for Recurrent Clostridium difficile-associated Diarrhea
The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Abstract
CDAD is the major known cause of antibiotic-induced diarrhea and colitis, and the disease is thought to result from persistent disruption of commensal gut microbiota.Bacteriotherapy by way of fecal transplantation can be used to treat recurrent CDAD and is thought to re-establish the normal colonic microflora.However, limitations of conventional microbiologic techniques have until recently precluded testing of this idea.In this study we used T-RFLP and 16S rRNA gene sequencing approaches to characterize the bacterial composition of the colonic microflora in a patient suffering from recurrent CDAD, before and after treatment by fecal transplantation from a healthy donor.While the patient's residual colonic microbiota, prior to therapy, was deficient in members of the bacterial divisions-Firmicutes and Bacteriodetes, transplantation had a dramatic impact on the composition of the patient's gut microbiota.By 14 days post transplantation, the fecal bacterial composition of the recipient was highly similar to the donor and was dominated by Bacteroides spp.strains and an uncharacterized butyrate producing bacterium.The change in bacterial composition was accompanied by resolution of the patient's symptoms.The striking similarity of the recipient's and donor's intestinal microbiota following bacteriotherapy suggests that the donor's bacteria quickly occupied their requisite niches, resulting in restoration of both the structure and function of the microbial communities present.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Multiple studies have demonstrated remarkable effectiveness of FMT in cases of recurrent and refractory CDI, which may be attributed to sustained restoration of the normal microbiota after FMT.22,23”
From Fecal microbiota transplantation: Review and update (2019) · cites this paper as [22]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“Indeed, studies have demonstrated that patients suffering from recurrent CDI are deficient in phyla of bacteria normally dominant in the colon6,45 (Figure 1).”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [6]
In the citing paper
“Moreover, the restoration of more typical microbial communities, which come to resemble those of the donor post-transplant, persists in a durable fashion after FMT.6, 7”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [6]
In the citing paper
“FMT appears to result in durable engraftment of new species from donor as well as augmentation of species present at only very low levels prior to FMT6.”
From Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook (2015) · cites this paper as [6]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
An obesity-associated gut microbiome with increased capacity for energy harvest
Turnbaugh, P. J., Ley, R. E., Mahowald, M. A., Magrini, V., Mardis, E. R., & Gordon, J. I. (2006) · Nature · doi:10.1038/nature05414 · Cited by 12,444
Muyzer, G., de Waal, E. C., & Uitterlinden, A. G. (1993) · Applied and Environmental Microbiology · doi:10.1128/aem.59.3.695-700.1993 · Cited by 11,429
Human gut microbes associated with obesity
Ley, R. E., Turnbaugh, P. J., Klein, S., & Gordon, J. I. (2006) · Nature · doi:10.1038/4441022a · Cited by 8,785 · cited 1×
“Many Firmicutes produce butyrate and are postulated to be involved in obesity in humans and murine models.(32,33) Short chain length fatty acids (SCFAs), especially butyrate, have also been shown to play a critical role in maintaining integrity of the colonic epithelium and regulation of the mucosal immune responses.”
BackgroundDiversity of the Human Intestinal Microbial Flora
Eckburg, P. B., Bik, E. M., Bernstein, C. N., Purdom, E., Dethlefsen, L., Sargent, M., Gill, S. R., Nelson, K. E., & Relman, D. A. (2005) · Science · doi:10.1126/science.1110591 · Cited by 7,913
Ecological and Evolutionary Forces Shaping Microbial Diversity in the Human Intestine
Ley, R. E., Peterson, D. A., & Gordon, J. I. (2006) · Cell · doi:10.1016/j.cell.2006.02.017 · Cited by 3,358 · cited 1×
“These bacteria are well-known dominant members of human fecal microbiota,(16) and these phyla are thought to play major ecologic roles in establishment and maintenance of gut homeostasis.(30) A lack of Bacteroides sp.”
BackgroundDevelopment of the Human Infant Intestinal Microbiota
Palmer, C., Bik, E. M., DiGiulio, D. B., Relman, D. A., & Brown, P. O. (2007) · PLoS Biology · doi:10.1371/journal.pbio.0050177 · Cited by 2,877
Edwards, U., Rogall, T., Blöcker, H., Emde, M., & Böttger, E. C. (1989) · Nucleic Acids Research · doi:10.1093/nar/17.19.7843 · Cited by 2,724 · cited 1×
“primers Bact-8F (5’-AGAGTTTGATCCTGGCTCAG-3’) [25] 5′ end-labeled with 6-”
Dethlefsen, L., Huse, S., Sogin, M. L., & Relman, D. A. (2008) · PLoS Biology · doi:10.1371/journal.pbio.0060280 · Cited by 2,361
Clostridium difficile— More Difficult Than Ever
Kelly, C. P., & LaMont, J. T. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0707500 · Cited by 1,313 · cited 4×
“Unfortunately, the same problem is encountered by others treating this disease.(1) In the studies reported here, we used a molecular approach to gain a better understanding of the bacterial composition of the GI tract in a CDAD patient.”
BackgroundInfluentialDecreased Diversity of the Fecal Microbiome in Recurrent Clostridium difficile–Associated Diarrhea
Chang, J. Y., Antonopoulos, D. A., Kalra, A., Tonelli, A., Khalife, W. T., Schmidt, T. M., & Young, V. B. (2008) · The Journal of Infectious Diseases · doi:10.1086/525047 · Cited by 1,010 · cited 2×
“However, the composition and species richness of intestinal tract microbiota in individuals with CDAD and recurrent CDAD were found to be markedly different from controls.(14) The reestablishment of the normal composition of the intestinal flora has long been hypothesized to be a curative approach for the recurrent CD…”
Background
Cited by
Items 401–500 of 645
Conventional and alternative treatment approaches for Clostridium difficile infection.
Aljarallah, K. M. (2017) · PubMed Central · Cited by 26
Lübbert, C., Salzberger, B., & Mössner, J. (2017) · Der Internist · doi:10.1007/s00108-017-0203-6 · Cited by 24
“Innerhalbderersten beiden Wochen nach Stuhlübertragung entwickelt sich eine hochdiverse protektive Spenderflora mit Prädominanz natürlicher Bacteroides-Spezies ([22]; .”
Green Tea as an Agricultural Based Health Promoting Food: The Past Five to Ten Years
Shi, Q.-Y., & Schlegel, V. L. (2012) · Agriculture · doi:10.3390/agriculture2040393 · Cited by 20
Diversity-Function Relationships in Natural, Applied, and Engineered Microbial Ecosystems
Free, A., McDonald, M. A., & Pagaling, E. (2018) · Advances in applied microbiology · doi:10.1016/bs.aambs.2018.07.002 · Cited by 19
“Such disturbance is, however, easier to achieve in a bioreactor or even a human GI tract (via colonic washout (Khoruts et al., 2010)) than in the natural environment.”
BackgroundEmerging drugs for the treatment of clostridium difficile
Cammarota, G., Gallo, A., Ianiro, G., & Montalto, M. (2019) · Expert Opinion on Emerging Drugs · doi:10.1080/14728214.2019.1591371 · Cited by 20
Clostridium difficile Infection in the Postcolectomy Patient
Seril, D. N., & Shen, B. (2014) · Inflammatory Bowel Diseases · doi:10.1097/mib.0000000000000164 · Cited by 21
Immune-based treatment and prevention ofClostridium difficileinfection
Song, Z., Ghose, C., Zhang, K., Tzipori, S. R., & Sun, X. (2014) · Human Vaccines & Immunotherapeutics · doi:10.4161/21645515.2014.980193 · Cited by 19
Trasplante de microbiota fecal
de Paredes, A. G. G., de Santiago, E. R., Aguilera, L., Ferre‐Aracil, C., & López–Sanromán, A. (2014) · Gastroenterología y Hepatología · doi:10.1016/j.gastrohep.2014.07.010 · Cited by 32
Gunardi, T. H., Susantono, D. P., Victor, A. A., & Sitompul, R. (2021) · Journal of Ophthalmic and Vision Research · doi:10.18502/jovr.v16i4.9754 · Cited by 19
“Desirable outcome of FMT has been reported in numerous studies mentioning various organs, from infection to autoimmune origin, for example, Clostridium dificille infection,[35, 36] irritable bowel disease,[37] chronic fatigue syndrome,[38] nonalcoholic fatty liver disease, idiopathic thrombocytopenic purpura,[39] and…”
BackgroundResearch progress of gut microbiota in hepatocellular carcinoma
Li, K., Liu, J., & Qin, X. (2022) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.24512 · Cited by 19
Introduction to geomicrobiology
Kirchman, D. L. (2011) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199586936.003.0013 · Cited by 18
Fecal microbiota transplant for Clostridium difficile infection in older adults
Tauxe, W. M., Haydek, J. P., Rebolledo, P. A., Neish, E., Newman, K. L., Ward, A., Dhere, T., & Kraft, C. S. (2015) · Therapeutic Advances in Gastroenterology · doi:10.1177/1756283x15622600 · Cited by 19
A clinical primer of the role of gut microbiome in health and disease
Yang, A. L., & Kashyap, P. (2015) · Tropical Gastroenterology · doi:10.7869/tg.238 · Cited by 19
“Longitudinal studies following transplantation have shown that use of donor feces quickly leads to donor-like composition of the gut microbiota in recipients.(86,87) More recently, the direction of research has focused on a second methodology involving”
BackgroundMucosal immunology and bacterial handling in the intestine
Rescigno, M. (2013) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2013.03.004 · Cited by 21
“This activity has to be considered within the context of the whole microbiota as different species (and within each species different strains) can have diverse effects on immune cells [58–60].”
BackgroundCultivation of Epithelial-Associated Microbiota by The Immune System
Thomas, A. D., & Parker, W. (2010) · Future Microbiology · doi:10.2217/fmb.10.108 · Cited by 18
“Furthermore, the use of antibiotics might be expected to work in some regards against the immune system rather than in concert with the immune system and ‘fecal transplants’, which have the potential to restore normal microbiomes in some patients [99], may be viewed as working in concert with the immune system rather…”
BackgroundResearch Progress in Fecal Microbiota Transplantation as Treatment for Irritable Bowel Syndrome
Wang, Y., Zheng, F., Liu, S., & Luo, H. (2019) · Gastroenterology Research and Practice · doi:10.1155/2019/9759138 · Cited by 18
“(4) A case report in 2012 indicated that the use of standardized frozen feces was not statistically different from the use of fresh feces [86].”
BackgroundAlcohol pretreatment of stools effect on culturomics
Afouda, P., Hocquart, M., Pham, T.-P.-T., Kuete, E., Ngom, I. I., Dione, N., Valles, C., Bellali, S., Lagier, J., Dubourg, G., et al. (2020) · Scientific Reports · doi:10.1038/s41598-020-62068-x · Cited by 18
Degradation of organic material
Kirchman, D. L. (2011) · Oxford University Press eBooks · doi:10.1093/acprof:oso/9780199586936.003.0005 · Cited by 20
Cecal Microbiota in Broilers Fed with Prebiotics
Mesa, D., Lammel, D. R., Balsanelli, E., Sena, C., Noseda, M. D., Caron, L. F., Cruz, L. M., Pedrosa, F. O., & de Souza, E. M. (2017) · Frontiers in Genetics · doi:10.3389/fgene.2017.00153 · Cited by 19
“Because the microbiota can be modified (Khoruts et al., 2010; Borody and Khoruts, 2012) it constitutes an attractive target for therapeutic manipulation.”
BackgroundFecal Microbiota Transplantation and Emerging Treatments for Clostridium difficile Infection
Gens, K. D., Elshaboury, R. H., & Holt, J. (2013) · Journal of Pharmacy Practice · doi:10.1177/0897190013499527 · Cited by 17
“Overall, fecal microbiota composition of the study patient showed marked similarity to that of the donor, while exhibiting rapid and complete recovery of symptoms during the study period.(21) The final study by Grehan et al examined 10 patients aged 22 to 57 years with IBS, Crohn’s disease, or constipation and 4 male…”
ResultAn Integrated Outlook on the Metagenome and Metabolome of Intestinal Diseases
Aw, W., & Fukuda, S. (2015) · Diseases · doi:10.3390/diseases3040341 · Cited by 14
“FMT has been reported to be beneficial in antibiotic-associated diarrhea or Clostridium difficile infection [110–112].”
BackgroundThe immune interactions of gut glycans and microbiota in health and disease
(2024) · doi:10.1111/mmi.15267 · Cited by 14
Xie, W., Sharma, A., Kaushik, H. K., Sharma, L., Nistha, Anwer, M. K., Sachdeva, M., Elossaily, G. M., Zhang, Y., Pillappan, R., et al. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e35336 · Cited by 16
“These interactions have the potential to result in unforeseen side effects or modifications in drug efficacy, underscoring the intricate interplay between microbiota, microbial metabolites, and drug therapy [153].”
BackgroundTransport stress affects the fecal microbiota in healthy donkeys
Jiang, G., Zhang, X., Gao, W., Ji, C., Wang, Y., Feng, P., Feng, Y., Zhang, Z., Li, L., & Zhao, F. (2021) · Journal of Veterinary Internal Medicine · doi:10.1111/jvim.16235 · Cited by 15
Ashraf, M. F., Tageldin, O., Nassar, Y., & Batool, A. (2021) · Gastroenterology Research · doi:10.14740/gr1436 · Cited by 16
“Fecal microbiota transplantation (FMT) from healthy individuals to these patients can restore healthy flora in the gut, thus breaking the cycle of recurrent infection [3].”
BackgroundBio‐banking gut microbiome samples
Bolan, S., Seshadri, B., Talley, N. J., & Naidu, R. (2016) · EMBO Reports · doi:10.15252/embr.201642572 · Cited by 14
Seekatz, A. M., Bassis, C. M., Fogg, L., Moore, N. M., Rhee, Y., Lolans, K., Weinstein, R. A., Lin, M. Y., Young, V. B., & Hayden, M. K. (2018) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofy190 · Cited by 15
Stool Transplants: Ready for Prime Time?
Weissman, J., & Coyle, W. (2012) · Current Gastroenterology Reports · doi:10.1007/s11894-012-0263-7 · Cited by 14
“with recurrent CDI show significantly more microbiome heterogeneity than those with a single episode of CDI or healthy controls [12].”
BackgroundCorrelating the Gut Microbiome to Health and Disease
Marques, T. M., Holster, S., Wall, R., König, J., Brummer, R. J., & de Vos, W. M. (2016) · Elsevier eBooks · doi:10.1016/b978-0-12-802304-4.00012-8 · Cited by 16
Drew, L. (2016) · Nature · doi:10.1038/540s109a · Cited by 12
The Multiomics Analyses of Fecal Matrix and Its Significance to Coeliac Disease Gut Profiling
Gangadoo, S., Rajapaksha, P., Cheeseman, S., Dang, Y., Elbourne, A. J., Cozzolino, D., Latham, K., Truong, V. K., & Chapman, J. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041965 · Cited by 14
New drug discovery strategies for targeting drug-resistant bacteria
Popova, K. B., Valsamatzi-Panagiotou, A., & Prof. Robert Penchovsky, D. R. N. (2021) · Environmental Chemistry Letters · doi:10.1007/s10311-021-01181-3 · Cited by 13
New Drugs and Strategies for Management of Clostridium difficile Colitis
Higa, J. T., & Kelly, C. P. (2013) · Journal of Intensive Care Medicine · doi:10.1177/0885066613475426 · Cited by 13
“Posttransplant evaluations show resurgence of native Bacteroides species frequently missing in the flora of those afflicted with CDI.(69) There is some concern for possible spread of pathogenic organisms from donor to host, which may be of particular concern in immunocompromised hosts; hence, screening of donors for p…”
BackgroundManaging the Microbiome: How the Gut Influences Development and Disease
Weinstein, N., Garten, B., Vainer, J., Minaya, D. M., & Czaja, K. (2020) · Nutrients · doi:10.3390/nu13010074 · Cited by 15
“Following FMT, the patient’s microbiome composition closely resembled that of the donor, suggesting that healthy bacteria are able to effectively integrate with the recipient [41].”
BackgroundHerrera, G., Paredes‐Sabja, D., Patarroyo, M. A., Ramírez, J. D., & Muñoz, M. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1966277 · Cited by 13
“One such study reported a dramatic change in the recipient’s microbiota composition 14 days after transplantation; similarity with donor microbiota was achieved, leading to symptom resolution.(64) However, such interventions were unsuccessful in some patients; this led to further research regarding specific components…”
BackgroundRegulatory Considerations for Microbiome-Based Therapeutics
Waheed, R., Farooq, A. Z., & Asma, L. (2024) · Springer eBooks · doi:10.1007/978-981-97-3790-1_21 · Cited by 26
Prebiotics to manage the microbial control of energy homeostasis
Grootaert, C., Marzorati, M., den Abbeele, P. V., de Wiele, T. V., & Possemiers, S. (2011) · Beneficial Microbes · doi:10.3920/bm2011.0020 · Cited by 14
“A final option could be the transfer of entire communities (or part of the microbial population) through faecal transplantation (Khoruts et al., 2010), as an extension of the concept of synbiotics.”
BackgroundBono‐Lunn, D., Villeneuve, C., Abdulhay, N. J., Harker, M. J., & Parker, W. (2016) · Clinical Research and Regulatory Affairs · doi:10.1080/10601333.2016.1210159 · Cited by 12
The Gut Microbiota and Inflammatory Bowel Disease
Conrad, M. A., Wu, G. D., & Kelsen, J. R. (2017) · Springer eBooks · doi:10.1007/978-3-319-49215-5_4 · Cited by 12
Lee, P., Chang, T.-E., Wang, Y., Lee, K., Lin, Y.-T., Chiou, J.-J., Huang, C.-W., Yang, U., Li, F.-Y., Huang, H., et al. (2021) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2021.11.001 · Cited by 13
Challenges and opportunities for faecal microbiota transplantation therapy
Rogers, G. B., & Bruce, K. D. (2013) · Epidemiology and Infection · doi:10.1017/s0950268813001362 · Cited by 14
Novel Chimeric Protein Vaccines Against Clostridium difficile Infection
Wang, S., Wang, Y., Cai, Y., Kelly, C. P., & Sun, X. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.02440 · Cited by 14
STRUCTURING A FECAL MICROBIOTA TRANSPLANTATION CENTER IN A UNIVERSITY HOSPITAL IN BRAZIL
Terra, D., Vilela, E. G., Silva, R. O. S., LEÃO, L. A., Karine Sampaio, L. I. M. A., PASSOS, R. I. F. Â., Diniz, A. N., & Coelho, L. G. V. (2020) · Arquivos de Gastroenterologia · doi:10.1590/s0004-2803.202000000-79 · Cited by 11
“Prior to transplantation, the microbiota presented reduction of Bacteroidetes and increase in atypical bacterial populations such as Veillonella, Clostridium, Lactobacillus, Streptococcus.”
BackgroundInfluentialTreatment of Refractory or RecurrentClostridium difficileInfection
Kim, S. W. (2012) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2012.60.2.71 · Cited by 12
“사한 균총 상태를 회복함으로써 치유를 일으키고 재발을 방지 하는 것으로 생각된다.(34) 근래의 체계적 문헌 고찰에 의하면 재발성/난치성 CDI 환 자 317명을 대상으로 한 28개 연구를 종합한 결과 92%의 환 자에서 증상이 회복되었다.”
Lee, J.-E., & Kim, Y.-Y. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2017.0197 · Cited by 11
“Fecal microbiota transplantation from healthy individual to patient could become a therapeutic method for treatment of some diseases (Khoruts et al., 2010).”
MethodCorrigan, A., Russell, N. T., Welge, M. E., Auvil, L. S., Bushell, C., White, B. A., & Murphy, R. A. (2018) · Scientific Reports · doi:10.1038/s41598-018-31438-x · Cited by 16
Gao, Y., Li, H., Yang, H., Su, J., & Huang, L. (2019) · Critical Reviews in Microbiology · doi:10.1080/1040841x.2019.1700905 · Cited by 11
Clostridium difficile Infection in Children
Noor, A., & Krilov, L. R. (2018) · Pediatric Annals · doi:10.3928/19382359-20180803-01 · Cited by 11
A Proteogenomic Approach to Unveiling the Complex Biology of the Microbiome
Pavelescu, L. A., Profir, M., Enache, R. M., Roşu, O. A., Creţoiu, S. M., & Gașpar, B. S. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms251910467 · Cited by 10
“However, metaproteomic and metagenomic studies have demonstrated that the variability of the recipient ′ s microbiota is restored with normal commensal bacteria approximately two weeks after fecal transplantation, with Bacteroidetes becoming the dominant group [98,99].”
BackgroundMetagenomics and Community Profiling: Culture-Independent Techniques in the Clinical Laboratory
Willner, D. L., & Hugenholtz, P. (2012) · Clinical Microbiology Newsletter · doi:10.1016/j.clinmicnews.2012.12.001 · Cited by 10
Yang, F., Chia, N., White, B. A., & Schook, L. B. (2013) · BMC Bioinformatics · doi:10.1186/1471-2105-14-136 · Cited by 21
“Recent work has correlated the alleviation of disease symptoms with treatments that alter the microbiota such as fecal transplants [12].”
BackgroundResultInfluentialGrimnes, G., Bhoelan, S., Hindberg, K., Davids, M., Nieuwdorp, M., Mollnes, T. E., Michelsen, A. E., Ueland, T., Brækkan, S. K., Hansen, J., et al. (2021) · Thrombosis and Haemostasis · doi:10.1055/s-0041-1733906 · Cited by 11
Efficacy of oral fecal bacteriotherapy in rhesus macaques (Macaca mulatta) with chronic diarrhea.
Ferrecchia, C. E., & Hobbs, T. R. (2013) · Europe PMC (PubMed Central) · Cited by 13
Evolutionary Game between Commensal and Pathogenic Microbes in Intestinal Microbiota
Wu, A. W., & Ross, D. (2016) · Games · doi:10.3390/g7030026 · Cited by 11
“Which shifts the microbiota composition of the recipient toward that of the donor [12] (p.”
BackgroundThe journey of gut microbiome – An introduction and its influence on metabolic disorders
Chattopadhyay, A., & Sathiavelu, M. (2018) · Frontiers in Biology · doi:10.1007/s11515-018-1490-6 · Cited by 11
“The microbiota was restored and resembles that of the healthy donor’s gut microbial community (Khoruts et al., 2010).”
BackgroundBaliou, S., Adamaki, M., Spandidos, D. A., Kyriakopoulos, A. M., Christodoulou, I., & Zoumpourlis, V. C. (2018) · World Academy of Sciences Journal · doi:10.3892/wasj.2018.6 · Cited by 11
Gonzales-Luna, A. J., Spinler, J. K., Oezguen, N., Khan, M. A. W., Danhof, H. A., Endres, B. T., Alam, M. J., Begum, K., Lancaster, C. K., da Costa, G. A. P. C., et al. (2021) · Anaerobe · doi:10.1016/j.anaerobe.2021.102387 · Cited by 10
Roles of Enteric Microbial Composition and Metabolism in Health and Diseases
Kim, J. M. (2013) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2013.62.4.191 · Cited by 10
The Intestinal Microbiota and Human Disease
Ko, J. S. (2013) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2013.62.2.85 · Cited by 13
“difficile 감염 환자에게 타인의 대변 미생물총을 이식하는 치료가 효과적인데, 이식 전에는 Firmicutes와 Bacteroidetes문이 부족했던 환자의 대변에서 이식 후에 증 상의 호전과 함께 기증자의 미생물총과 유사하게 Bacteroides종이 늘어나는 것이 관찰된다.(61) 반복적인 C.”
Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel
Na’amnih, W., Adler, A., Miller-Roll, T., Cohen, D., & Carmeli, Y. (2018) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-018-3247-1 · Cited by 10
“Interestingly, restoration of the healthy microbiota by fecal microbiota transplantation is very effective in patients with recurrent CDI [21, 22].”
BackgroundFecal microbiota transplantation for recurrent Clostridioides difficile infection
Haber, S. L., Raney, C. R. K., Larson, T., & Lau, J. P. (2019) · American Journal of Health-System Pharmacy · doi:10.1093/ajhp/zxz078 · Cited by 11
Gweon, T., Choi, M., Lee, S. K., Ha, J., Kim, E. Y., Go, B. S., & Kim, S. W. (2013) · Korean Journal of Medicine · doi:10.3904/kjm.2013.84.3.395 · Cited by 9
“이식 전후에 환 자의 장내 세균 분포가 기증자와 비슷해졌다는 보고들이 있다[5,6].”
The Human Microbiome and the Immune System: An Ever Evolving Understanding
Rivera‐Amill, V. (2014) · Journal of Clinical & Cellular Immunology · doi:10.4172/2155-9899.1000e114 · Cited by 13
“For example, several studies have shown that FMT provides its therapeutic benefit by re-establishing a balanced microbiota in in patients with recurrent Clostridium difficile infection (RCDI) [28,29].”
BackgroundQuera, R., Patricio Ibáñez, L., Simian, D., Rivera, D., Guillermo Acuña, L., & Espinoza, R. (2018) · Revista médica de Chile · doi:10.4067/s0034-98872018000800823 · Cited by 11
Jouhten, H., Ronkainen, A., Aakko, J., Salminen, S., Mattila, E. J., Arkkila, P., & Satokari, R. M. (2020) · Frontiers in Microbiology · doi:10.3389/fmicb.2020.01663 · Cited by 10
Probiotics and fecal microbiota transplantation in surgical disorders
Yeh, A., & Morowitz, M. J. (2017) · Seminars in Colon and Rectal Surgery · doi:10.1053/j.scrs.2017.09.007 · Cited by 10
Neurocritical Care Management of Hepatic Encephalopathy and Coma in Liver Failure
Kerbert, A. J. C., Engelmann, C., & Jalan, R. (2018) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0038-1672180 · Cited by 10
“Fecal microbiota transplantation is a novel approach to restore dysbiosis [162] and seems to”
BackgroundTran, V., Phan, J., Nulsen, B., Huang, L., Kaneshiro, M., Weiss, G. A., Ho, W. W., Sack, J. L., Ha, C. Y., Uslan, D. Z., et al. (2018) · ACG Case Reports Journal · doi:10.14309/crj.2018.97 · Cited by 9
“Because of the increasing use of FMT for recurrent CDI in patients with IBD, it is important to further understand the effect of this therapy on patients with active and inactive IBD.6 Prospective studies will help elucidate optimal patient selection and timing of IBD treatment optimization and FMT in patients with IB…”
BackgroundInfluentialCommunity metabolic modeling of host-microbiota interactions through multi-objective optimization
Lambert, A., Budinich, M., Mahé, M. M., Chaffron, S., & Eveillard, D. (2024) · iScience · doi:10.1016/j.isci.2024.110092 · Cited by 11
Blair, M. F., Garner, E., Ji, P., & Pruden, A. J. (2024) · Environmental Science & Technology · doi:10.1021/acs.est.4c04679 · Cited by 8
Klinhom, S., Kunasol, C., Sriwichaiin, S., Kerdphoo, S., Chattipakorn, N., Chattipakorn, S. C., & Thitaram, C. (2025) · Scientific Reports · doi:10.1038/s41598-025-85495-0 · Cited by 10
“Therefore, a decrease in its relative abundance has been associated with chronic diarrhea in humans 46 .”
Towards airway microbiome engineering for improving respiratory health
Hern, K. E., & Prindle, A. B. (2025) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2025.115662 · Cited by 8
Therapeutic Approaches for Clostridium difficile Infections
Marsh, J. W., & Curry, S. R. (2013) · Current Protocols in Microbiology · doi:10.1002/9780471729259.mc09a03s30 · Cited by 8
“In a study examining the fecal composition of a recurrent CDI patient pre- and 14 days post-transplant, the patient’s intestinal microbiota resembled the donor’s, suggesting that donor’s bacteria had established itself and prevented further disease relapse (Khoruts et al., 2010).”
BackgroundTrasplante de microbiota fecal: primer caso reportado en Chile y revisión de la literatura
Espinoza, R., Quera, R., Meyer, L., & Rivera, D. (2014) · Revista chilena de infectología · doi:10.4067/s0716-10182014000400016 · Cited by 15
Le transfert de flore digestive : une revue de la littérature
Barbut, F., Collignon, A., Butel, M. J., & Bourlioux, P. (2014) · Annales Pharmaceutiques Françaises · doi:10.1016/j.pharma.2014.05.004 · Cited by 12
Meléndez-Vázquez, N. M., Gomez‐Manzano, C., & Godoy‐Vitorino, F. (2024) · Viruses · doi:10.3390/v16111775 · Cited by 8
“In 2010, a patient with chronic diarrhea due to an infection from Clostridium difficile achieved a successful gut microbiota restoration after an FMT from a healthy donor [192].”
Colombo, N. S. R., Ross, R. P., & Hill, C. (2025) · Gut Microbes · doi:10.1080/19490976.2025.2451081 · Cited by 8
“1,5,22,23 However, CDI predominantly affects immuno-compromised patients who frequently undergo prolonged antibiotic treatments and are often ineligible for FMT due to their weakened immune systems.”
Gut microbial dysbiosis aggravated Parkinson-like pathology induced by MPTP/probenecid
Chen, Q.-Z., Shang, J., Jiang, Y., Yang, Y., Zang, C., Ma, J., Dong, Y.-R., Wang, J., Zhou, N., Yang, X., et al. (2025) · Physiology & Behavior · doi:10.1016/j.physbeh.2025.115008 · Cited by 7
Fecal Microbiota Transplantation for the Management of Clostridium difficile Infection
Paknikar, R., & Pekow, J. R. (2018) · Surgical Infections · doi:10.1089/sur.2018.221 · Cited by 8
“The mechanism of FMT is somewhat debatable but appears to be because of successful retention of donor stool content in the recipient in addition to augmentation of species present in the recipient at low levels before FMT [38].”
BackgroundGenomics of Probiotic–Host Interactions
Ajithdoss, D. K., Dowd, S. E., & Suchodolski, J. S. (2011) · Springer eBooks · doi:10.1007/978-1-4614-1311-0_4 · Cited by 9
Therapeutic Potential of the Human Gastrointestinal Microbiome
Borody, T. J., Peattie, D. A., & Campbell, J. (2013) · Drug Development Research · doi:10.1002/ddr.21093 · Cited by 8
“Patients with CDI have deficiencies in fecal flora composition, particularly of Bacteroides and Firmicutes [Tvede and Rask-Madsen, 1989; Khoruts et al., 2010].”
BackgroundThe Current and Future Role of Drugs and Probiotics in the Management of Inflammatory Bowel Disease
de Souza, M. D. S. S., Barbalho, S. M., Goulart, R. D. Á., & de Carvalho, A. D. C. A. (2015) · Journal of Biosciences and Medicines · doi:10.4236/jbm.2015.38008 · Cited by 9
“Authors believe that in a near future, intestinal bacterial flora will be controlled by probiotics but their use needs to be safe using microorganisms with General Recognized as Safe status [6] [53]-[57].”
BackgroundFecal microbiota transplantation for management of Clostridium difficile infection
Vaishnavi, C. V. (2014) · Indian Journal of Gastroenterology · doi:10.1007/s12664-014-0459-x · Cited by 10
“[28] treated CDI by FMT and found that 14 days after the transplantation, the fecal bacterial flora was similar to that of their donor.”
BackgroundSamuel, B. P., Crumb, T. L., & Duba, M. M. (2014) · Journal of Pediatric Nursing · doi:10.1016/j.pedn.2014.01.013 · Cited by 9
Grain Sorghum Lipids: Extraction, Characterization, and Health Potential
Lee, B. H., Weller, C. L., Cuppett, S. L., Carr, T. P., Walter, J., Martínez, I., & Schlegel, V. L. (2011) · ACS symposium series · doi:10.1021/bk-2011-1089.ch008 · Cited by 9
Coprophagy in nineteenth-century psychiatry
Moore, A. M. D. (2018) · Microbial Ecology in Health and Disease · doi:10.1080/16512235.2018.1535737 · Cited by 8
A depressed gut makes for a depressed brain via vagal transmission
Munshi, S. (2021) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2021.03.017 · Cited by 7
Isolation and gut microbiota modulation of antibiotic-resistant probiotics from human feces
Tian, P., Xu, B., Sun, H., Li, X., Li, Z., & Wei, P. (2014) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2014.04.002 · Cited by 8
Lactic Acid Bacteria and the Human Gastrointestinal Tract
Kwok, L. Y. (2014) · Springer eBooks · doi:10.1007/978-94-017-8841-0_6 · Cited by 11
Cultural and Personal Considerations in Informed Consent for Fecal Microbiota Transplantation
Bokek‐Cohen, Y., & Ravitsky, V. (2017) · The American Journal of Bioethics · doi:10.1080/15265161.2017.1299241 · Cited by 7
Souza, D. T., Moreira, A. C. S., Quevedo, H. D., & May, A. (2025) · Microorganisms · doi:10.3390/microorganisms13061177 · Cited by 8
“The concept of microbial transplantation, originally explored in biomedicine and microbial ecology, now offers a scalable and sustainable solution for agricultural soil restoration [23].”
Current epidemiology and treatment ofClostridium difficileinfection
Pai, H. (2010) · Infection and Chemotherapy · doi:10.3947/ic.2010.42.6.362 · Cited by 6
Fecal Bacteriotherapy for Recurrent Clostridium difficile Infection: What’s Old Is New Again?
Suwantarat, N., & Bobak, D. A. (2013) · Current Infectious Disease Reports · doi:10.1007/s11908-013-0314-8 · Cited by 7
Dahiya, M., Jovel, J., Monaghan, T. M., Wong, K., Elhenawy, W., Chui, L., McAlister, F. A., & Kao, D. H. (2023) · Microorganisms · doi:10.3390/microorganisms11041078 · Cited by 6
“Following FMT, intestinal microbial diversity is restored in the recipient, resembling that of the stool donor [14].”
BackgroundInfluentialMicrobiomics: An Approach to Community Microbiology
Sharma, P., Brahma, V., Sharma, A., Dubey, R. K., Sidhu, G. S., & Malhotra, P. K. (2015) · Springer eBooks · doi:10.1007/978-81-322-2172-2_22 · Cited by 7
Fecal microbiota transplantation: An innovative approach to treating Clostridium difficile disease
Paasché, S. (2013) · JAAPA · doi:10.1097/01.jaa.0000432570.98817.16 · Cited by 6
Tanaka, T., Kato, H., & Fujimoto, T. (2016) · Internal Medicine · doi:10.2169/internalmedicine.55.5701 · Cited by 6
“Following FMT, the intestinal microbiota of the recipient resembles that of the donor (7).”
BackgroundIntestinal Microbiota Composition in Adults
Robles, V., & Guarner, F. (2013) · World review of nutrition and dietetics · doi:10.1159/000346875 · Cited by 8
The Human Microbiome in Health and Disease
Hill, C. J., Ross, R. P., Stanton, C., & O’Toole, P. W. (2016) · Wiley eBooks · doi:10.1002/9783527682386.ch4 · Cited by 7
Jia, J., Wu, Y., Liu, S., Chen, W., Li, R., Bai, Y., & Hu, L. (2025) · Frontiers in Medicine · doi:10.3389/fmed.2025.1593483 · Cited by 5
“Unlike antibiotics, FMT increases the diversity of fecal bacterial populations in recipients, likely contributing to its success in C. difficile infection (113, 114).”
Metadata
- Authors
- Khoruts, A., Dicksved, J., Jansson, J. K., & Sadowsky, M. J.
- Affiliations
- University of Minnesota (US)
- Swedish University of Agricultural Sciences (SE)
- Lawrence Berkeley National Laboratory (US)
- Corresponding author
- Khoruts, Alexander
- Venue
- Journal of Clinical Gastroenterology
- Published
- 2010-05
- Volume
- 44
- Issue
- 5
- Pages
- 354-360
- ISSN
- 0192-0790 (ISSN-L)
- OpenAlex
- W2095040140
- Cited by
- 649
- References
- 37
- Citations by year
- 2026: 6 · 2025: 15 · 2024: 22 · 2023: 14 · 2022: 13 · 2021: 26 · 2020: 29 · 2019: 41 · 2018: 49 · 2017: 49 · 2016: 53 · 2015: 49 · 2014: 69 · 2013: 88 · 2012: 47
- FWCI
- 44.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Journal of Clinical Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- Clostridium difficile-associated diarrhea, fecal microbiota transplantation, gut microbiota composition, colonic microbiota, Firmicutes, Bacteroidetes, Bacteroides, butyrate-producing bacteria, antibiotic-associated diarrhea
- MeSH terms
- Enterocolitis, Pseudomembranous, Feces, Female, Follow-Up Studies, Humans, Middle Aged, Polymorphism, Restriction Fragment Length, RNA, Ribosomal, 16S, Clostridioides difficile, Sequence Analysis, RNA, Metagenome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.